Beam Therapeutics names Eric Foster as chief commercial officer

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/3/2026

1. SNOW
2. AVGO
3. RARE
4. HPE
5. FIVE
6. SPY
7. VRTS
8. NTAP
9. NTSK
10. OLLI

Go back to Beam Therapeutics names Eric Foster as chief commercial officer
Beam Inc. (NASDAQ: BEAM) Delayed: 29.08 -0.21 (0.72%)
Previous Close $29.29    52 Week High $83.60 
Open $29.49    52 Week Low $82.96 
Day High $29.65    P/E 12.98 
Day Low $28.02    EPS $2.24 
Volume 564,692